Pfizer

News

Pfizer begins clinical trials of COVID-19 antiviral pill

Pfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at the first sign of infection.

Events

Partner Content

RBQM Live: The Definitive Guide to RBQM for Experts and Begi...

RBQM Live two-day virtual event May 20-21

News

Red spine and vertebral column of a human skeleton

FDA worried about Pfizer/Lilly pain drug safety ahead of key...

After a long and troubled development the fate of Pfizer/Lilly’s tanezumab painkiller injection is in the balance ahead of a key meeting of advisers later this week.

News

Belgium's eTheRNA gets EU grant to develop mRNA cancer vacci...

Belgian immunotherapy firm eTheRNA has received a €6.9 million grant from the European Commission to accelerate clinical development of mRNA therapies for hard-to-treat cancers.

News

Regulators questioned integrity of Pfizer/BioNTech vaccine, ...

European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online fol

News

Sanofi/Translate start clinical trial of mRNA COVID shot

Sanofi and Translate BIO have begun a clinical trial of their potential mRNA COVID-19 shot, as the French pharma struggles to keep pace with rivals despite its background in vaccines.

Pfizer begins clinical trials of COVID-19 antiviral pill

RBQM Live: The Definitive Guide to RBQM for Experts and Begi...

FDA worried about Pfizer/Lilly pain drug safety ahead of key...

Belgium's eTheRNA gets EU grant to develop mRNA cancer vacci...

Regulators questioned integrity of Pfizer/BioNTech vaccine, ...

Sanofi/Translate start clinical trial of mRNA COVID shot

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks